Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. - Wikidata - awgldk - TriplyDB

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

http://www.wikidata.org/entity/Q30688673

about

The clinical use of structural MRI in Alzheimer disease Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study Propagation of prions causing synucleinopathies in cultured cells Review: Multiple system atrophy: emerging targets for interventional therapies Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders Potential Interactions between the Autonomic Nervous System and Higher Level Functions in Neurological and Neuropsychiatric Conditions Glia and alpha-synuclein in neurodegeneration: A complex interaction Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom Multiple system atrophy: clinicopathological characteristics in Japanese patients.Natural history of multiple system atrophy in the USA: a prospective cohort study Acoustic Characteristics of Stridor in Multiple System Atrophy Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review.Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy.Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it?Vasomotor regulation in patients with multiple system atrophy.Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia.Evaluation of both perfusion and atrophy in multiple system atrophy of the cerebellar type using brain SPECT alone.Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy.Towards translational therapies for multiple system atrophy Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.Validity and reliability of a pilot scale for assessment of multiple system atrophy symptoms.Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?Multiple system atrophy: prognostic indicators of survival.Movement disorders: role of imaging in diagnosis.Camptocormia in Parkinson's disease.A randomized trial of mesenchymal stem cells in multiple system atrophy.Hyperintense putaminal rim at 1.5 T: prevalence in normal subjects and distinguishing features from multiple system atrophy.Callosal tissue loss in multiple system atrophy--a one-year follow-up study.Multiple system atrophy: current and future approaches to management Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment.Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.Novel therapeutic approaches in multiple system atrophy Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.

P2860

Q24609648-34887B4C-3BCD-4018-81B6-79BAE83CAEB0 Q24655620-F6D0D382-71A5-47FD-B9A0-1D3DAEB9B60E Q26269822-48506728-7D12-49EA-AB68-6AC3D3370680 Q26770919-6E4B71A3-BFC6-4925-9906-A8BABADB2412 Q26771536-517AF50D-2062-483A-9ED0-F68BDC2EC8B8 Q26779001-B8410200-4770-4674-8E88-49D30725492D Q26782934-3B099293-3F8A-475B-B0F1-67A30F97A846 Q26851153-A8353CC1-76CC-4623-A84B-04422B152048 Q28395248-887C5C80-CEC8-436D-8DA6-C081E680145D Q28740556-8E6B652B-9D13-4BEF-A7BC-DCBC9252D8EF Q30234494-D348493C-65BA-464C-AB12-DBB016189779 Q30279265-43AB29FC-0F90-41C1-88C7-668937C3AAF3 Q30384961-0BB55601-1B79-47F4-BF30-B5076565DF27 Q30480599-9FF13269-6D34-412C-A520-03E345348580 Q30714986-505F7E23-83BB-4901-A551-3C5C504F8D8E Q30851659-5D380E9F-4517-4854-9D06-F7C30555561D Q30984061-77E46894-567C-4019-B676-B61FBCD9BA72 Q33152820-8F6B3663-8A9F-431E-A42A-C0F0566C5519 Q33153613-48B88C79-CF6F-4E81-A3E4-9E8AD46CC84C Q33167884-8E87D58B-83F3-4829-A6AB-B22E1A405F70 Q33615626-06C45E02-F10D-4F92-AE51-47313E4D4864 Q33636262-8F8DEFED-E270-4D79-A0FE-091D1C63ABF9 Q33648258-1B58E1AC-CB91-4CE3-88A9-19BC2EC829E8 Q33654703-D8A2C364-3D2E-44EE-8B4E-827C2B015451 Q33750881-DCAD0829-77A4-4705-9343-07CE81A7E951 Q33797532-755CD913-7F90-4701-BD65-D68E71B0FA5D Q33805560-4C09E6A1-7011-4B62-B6C0-36037935C171 Q33868205-39C25115-4CBE-4113-A342-320513182A60 Q33891835-E6E5EF38-F534-4EFF-93EF-3B9D7DF85BA1 Q34071142-E21F048C-B872-4252-B252-EF4E4B9FE77E Q34136898-AB8A7F34-3963-4714-B8EF-52F0AB038CD7 Q34181112-89C49F58-450E-4275-83F6-33D511B6EE30 Q34290126-4098A346-150D-4DD1-9993-B3EBB7A560FA Q34307585-034926D2-57F4-4642-A652-3C563E7F95B4 Q34339151-73A25327-49D7-440C-8212-14F443CA84D8 Q34409502-8964EC3D-AA79-4908-A652-84DFCAE2AF6C Q34574023-525D87D4-8DB8-4AF8-B0DA-F36BD3BFC4EB Q34683979-BD8FF1B6-B3AB-4728-8B84-0141D131A89C Q34696470-EDBCFEA2-BF7A-43F0-A51E-45D1F2CAE18A Q34767058-3C3D6E6B-F384-4840-AAD3-0FF21BCBCB9B

P2860

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

http://www.wikidata.org/entity/Q30688673

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Progression and prognosis in m ...... ysis of 230 Japanese patients.

@ast

Progression and prognosis in m ...... ysis of 230 Japanese patients.

@en

type

label

Progression and prognosis in m ...... ysis of 230 Japanese patients.

@ast

Progression and prognosis in m ...... ysis of 230 Japanese patients.

@en

prefLabel

Progression and prognosis in m ...... ysis of 230 Japanese patients.

@ast

Progression and prognosis in m ...... ysis of 230 Japanese patients.

@en

P1433

Q30688673-2F5ADC87-AE35-4F63-9CC9-9690B97F29FB

P1476

Q30688673-58ACF48C-ED0B-4D00-AD5F-3533C30F519C

P2093

Q30688673-44C9A953-4BAF-46FA-AD67-F937779082D5

Q30688673-4A4F1822-BDC3-4C70-9943-98E0A11C2DC4

Q30688673-5B9748F8-04B2-4C3C-85B4-434BAEA17BAD

Q30688673-73B20702-549D-405C-8BD5-488544DFDC54

Q30688673-A4FBC6CC-11DC-45C8-97A9-64495E1C2183

Q30688673-A66177CF-B544-4BFF-A03A-1C105BE44C13

Q30688673-AF0E5AE7-ECD0-4622-BB0F-1F0B8FCC90EA

Q30688673-C6436571-823D-44F7-812A-8DE0B25169CF

Q30688673-C7444637-D786-4690-9485-230CED7B53F0

Q30688673-CCFFBD81-FD72-4FEE-BCC2-772FE7533EE4

P2860

Q30688673-07A1268A-FB4E-406F-AA80-7EB7B46788D1

Q30688673-0E0E21AF-DC21-47C4-8A58-EFA0CFD32178

Q30688673-0EB56BFA-9FBF-4154-B6AA-BF87236637CD

Q30688673-0F326E0B-BCEC-4759-85AD-93244848BC24

Q30688673-0F84C709-FB03-4A65-BE80-C1173F7EC620

Q30688673-12D4DB6A-88BB-4BEB-B1E5-A2290B33E3AD

Q30688673-12F2A3D8-67A4-491E-B6BB-A03ABCB8F001

Q30688673-18962CAB-96AA-4331-A3BD-796BC52ED43A

Q30688673-263AF43B-9DEC-4848-96D1-60C2F6506DDC

Q30688673-32597951-537B-4BC2-BC1B-A4FB93120A72

P304

Q30688673-2511EB79-FA44-436F-8974-C902F83046C7

P31

Q30688673-060478A6-FBCC-43C7-ABDA-694C3E91857B

P356

Q30688673-33E8BEB1-CEC4-4F32-876A-19EA6FF90757

P407

Q30688673-BDC259FC-E4C3-43A3-858A-8EBEBB22EF33

P433

Q30688673-3226A1D6-5200-4A3E-A4C4-82FF613BFB58

P478

Q30688673-C50E908F-67CD-497D-93F3-69AF66D06463

P50

Q30688673-3B759485-0B8B-4FC9-9144-F2AA628AC78F

P577

Q30688673-394AAE49-5D9E-4611-A637-255A75DD93A2

P5875

Q30688673-1B3D923A-DB4B-4E6E-A33D-C153CDD111FF

P698

Q30688673-D471AE8D-33EA-47B3-A427-17EAD70F3788

P356

P1433

P1476

Progression and prognosis in m ...... ysis of 230 Japanese patients.

@en

P2093

Akiko Tamakoshi

http://www.w3.org/2001/XMLSchema#string

Eiichiro Mukai

http://www.w3.org/2001/XMLSchema#string

Hirohisa Watanabe

http://www.w3.org/2001/XMLSchema#string

Ikuko Aiba

http://www.w3.org/2001/XMLSchema#string

Manabu Doyu

http://www.w3.org/2001/XMLSchema#string

Masaaki Hirayama

http://www.w3.org/2001/XMLSchema#string

Shinichi Terao

http://www.w3.org/2001/XMLSchema#string

Teruhiko Kachi

http://www.w3.org/2001/XMLSchema#string

Tetsuo Ando

http://www.w3.org/2001/XMLSchema#string

Yufuko Saito

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Widespread alterations of alpha-synuclein in multiple system atrophy

Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE.

Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology

Consensus statement on the diagnosis of multiple system atrophy.

Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT

Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy

Clinicopathological study of 35 cases of multiple system atrophy.

A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study.

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

P304

1070-1083

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWF117

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 5

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277479825

http://www.w3.org/2001/XMLSchema#string

P698

11960896

http://www.w3.org/2001/XMLSchema#string